ANXA5 and chronic myelogenous leukemia, BCR-ABL1 positive: Collated data from flow cytometry experiments with 3 independent CD34+ CML-CP cell samples showed 26 ± 1 versus 63 ± 16 % Annexin V+ (NDC versus 2 μM IB; p = 0.04, Figure 2A).